XCUR
Exicure Inc
$
7.490
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
7.550
Open
7.440
VWAP
7.51
Vol
4.12K
Mkt Cap
47.89M
Low
7.440
Amount
30.98K
EV/EBITDA(TTM)
--
Total Shares
8.65M
EV
40.03M
EV/OCF(TTM)
--
P/S(TTM)
--
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2022Q4
3.90M
+84.14%
--
--
Estimates Revision
Stock Price
Go Down
-36.85%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Exicure Inc (XCUR.O) is -0.14, compared to its 5-year average forward P/E of -1.10. For a more detailed relative valuation and DCF analysis to assess Exicure Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-1.10
Current PE
-0.14
Overvalued PE
0.40
Undervalued PE
-2.59
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
13.92
Current PS
0.51
Overvalued PS
61.79
Undervalued PS
-33.95
Financials
Annual
Quarterly
FY2025Q2
0.00
Total Revenue
FY2025Q2
YoY :
+108.02%
-2.57M
Operating Profit
FY2025Q2
YoY :
+336.83%
-2.62M
Net Income after Tax
FY2025Q2
YoY :
+17.14%
-0.41
EPS - Diluted
FY2025Q2
YoY :
-100.00%
N/A
Free Cash Flow
FY2025Q2
YoY :
-100.00%
N/A
Gross Profit Margin - %
FY2025Q2
YoY :
-100.00%
N/A
FCF Margin - %
FY2025Q2
YoY :
-100.00%
N/A
Net Margin - %
Trading Trends
Insider
Insiders areBuying! The selling amount has increased 1122.48% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
8.7M
USD
Months
0-12
1
711.7K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areBuying! The selling amount has increased 1122.48% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
8.7M
USD
Months
0-12
1
711.7K
USD
Months
XCUR News & Events
Events Timeline
2025-08-01 (ET)
2025-08-01
16:03:44
Exicure completes last patient in Phase 2 GPC-100 combo trial
2025-07-14 (ET)
2025-07-14
11:46:17
Exicure files to sell 5.16M shares of common stock for holders
2025-05-28 (ET)
2025-05-28
16:59:56
Exicure receives Nasdaq delinquency notice on late Form 10-Q filing
Sign Up For More Events
Sign Up For More Events
News
9.5
08-08NASDAQ.COMExicure Posts Wider Loss in Fiscal Q2
7.0
08-04NewsfilterExicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements
4.5
06-30TipRanksMorning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Sign Up For More News
People Also Watch
FEMY
Femasys Inc
0.775
USD
0.00%
CODX
Co-Diagnostics Inc
0.251
USD
-0.79%
ORKT
Orangekloud Technology Inc
0.775
USD
0.00%
NISN
Nisun International Enterprise Development Group Co Ltd
3.910
USD
0.00%
CVV
CVD Equipment Corp
3.680
USD
0.00%
CHR
Cheer Holding Inc
1.120
USD
0.00%
NAII
Natural Alternatives International Inc
3.700
USD
0.00%
FAQ
What is Exicure Inc (XCUR) stock price today?
The current price of XCUR is 7.49 USD — it has decreased -1.19 % in the last trading day.
What is Exicure Inc (XCUR)'s business?
What is the price predicton of XCUR Stock?
What is Exicure Inc (XCUR)'s revenue for the last quarter?
What is Exicure Inc (XCUR)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Exicure Inc (XCUR)'s fundamentals?
How many employees does Exicure Inc (XCUR). have?